210 related articles for article (PubMed ID: 15334243)
41. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery.
Ludlow CL; Naunton RF; Fujita M; Sedory SE
Otolaryngol Head Neck Surg; 1990 Feb; 102(2):122-31. PubMed ID: 2113236
[TBL] [Abstract][Full Text] [Related]
42. Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors.
Guglielmino G; Moraes BT; Villanova LC; Padovani M; Biase NG
Clinics (Sao Paulo); 2018 Jul; 73():e87. PubMed ID: 30020342
[TBL] [Abstract][Full Text] [Related]
43. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
[TBL] [Abstract][Full Text] [Related]
44. Office-based endoscopic botulinum toxin injection in laryngeal movement disorders.
Kaderbay A; Righini CA; Castellanos PF; Atallah I
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Jun; 135(3):205-207. PubMed ID: 29661610
[TBL] [Abstract][Full Text] [Related]
45. [The treatment of laryngeal movement disorders with botulinum toxin: part 2: experience and considerations].
Schwemmle C; Ptok M
HNO; 2007 Jun; 55(6):485-8. PubMed ID: 17431566
[TBL] [Abstract][Full Text] [Related]
46. Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection.
Ludlow CL; Naunton RF; Terada S; Anderson BJ
Otolaryngol Head Neck Surg; 1991 Jun; 104(6):849-55. PubMed ID: 1908979
[TBL] [Abstract][Full Text] [Related]
47. [Indications for botulinum toxin in laryngectomy].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E; Cohen M
Rev Laryngol Otol Rhinol (Bord); 1993; 114(4):281-7. PubMed ID: 8029549
[TBL] [Abstract][Full Text] [Related]
48. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.
Bhattacharyya N; Tarsy D
Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046
[TBL] [Abstract][Full Text] [Related]
49. Laryngeal myofascial pain syndrome as a new diagnostic entity of dysphonia.
Jung SY; Park HS; Bae H; Yoo JH; Park HJ; Park KD; Kim HS; Chung SM
Auris Nasus Larynx; 2017 Apr; 44(2):182-187. PubMed ID: 27262220
[TBL] [Abstract][Full Text] [Related]
50. Treatment of ventricular dysphonia with botulinum toxin.
Kendall KA; Leonard RJ
Laryngoscope; 1997 Jul; 107(7):948-53. PubMed ID: 9217137
[TBL] [Abstract][Full Text] [Related]
51. Teaching video NeuroImage: Spasmodic dysphonia: adductor and abductor.
Reich SG; Meyer T
Neurology; 2008 May; 70(19):e78. PubMed ID: 18458222
[No Abstract] [Full Text] [Related]
52. [Laryngeal dystonia. Comparison of transcutaneous and transoral injection of botulinum toxin].
García Ruiz PJ; Cenjor Español C; Sánchez Pernaute R; Astarloa R; Sánchez Bernardos V; García de Yébenes Prous J
Neurologia; 1996; 11(6):216-9. PubMed ID: 8768677
[TBL] [Abstract][Full Text] [Related]
53. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).
Brin MF; Blitzer A; Fahn S; Gould W; Lovelace RE
Mov Disord; 1989; 4(4):287-96. PubMed ID: 2811888
[TBL] [Abstract][Full Text] [Related]
54. Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection.
Rodriquez AA; Ford CN; Bless DM; Harmon RL
Electromyogr Clin Neurophysiol; 1994; 34(7):403-7. PubMed ID: 7859668
[TBL] [Abstract][Full Text] [Related]
55. Laryngeal dystonia: case report and treatment with botulinum toxin.
Santos VJ; Mattioli FM; Mattioli WM; Daniel RJ; Cruz VP
Braz J Otorhinolaryngol; 2006; 72(3):425-7. PubMed ID: 17119783
[TBL] [Abstract][Full Text] [Related]
56. Patient Experience Contributing to Outcomes of Laryngeal Botulinum Toxin Injection.
Rutt A; Kennelly KD; Martinez-Paredes JF
J Voice; 2022 Mar; 36(2):272-276. PubMed ID: 32553551
[TBL] [Abstract][Full Text] [Related]
57. Botulinum toxin type B for treatment of spasmodic dysphonia: a case report.
Sataloff RT; Heman-Ackah YD; Simpson LL; Park JB; Zwislewski A; Sokolow C; Mandel S
J Voice; 2002 Sep; 16(3):422-4. PubMed ID: 12395995
[TBL] [Abstract][Full Text] [Related]
58. [Adduction spastic dysphonia: clinical and treatment].
García Ruiz PJ; Sánchez del Río M; Cenjor Español C; Sanabria Brassart J; Sánchez Bernardos V; Astarloa Gómez R; García de Yébenes J
Rev Clin Esp; 1998 Mar; 198(3):156-8. PubMed ID: 9586438
[TBL] [Abstract][Full Text] [Related]
59. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia.
Ford CN; Bless DM; Lowery JD
Otolaryngol Head Neck Surg; 1990 Nov; 103(5 ( Pt 1)):752-8. PubMed ID: 2126097
[TBL] [Abstract][Full Text] [Related]
60. "Silent event-related" fMRI reveals reduced sensorimotor activation in laryngeal dystonia.
Haslinger B; Erhard P; Dresel C; Castrop F; Roettinger M; Ceballos-Baumann AO
Neurology; 2005 Nov; 65(10):1562-9. PubMed ID: 16301482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
